Niklas Klümper: New study on JAMA Oncology about long-term risks of prostate cancer treatments
Niklas Klümper, Senior Urology Consultant at the University Medical Center Bonn, shared a post on X about a recent paper by Joseph Unger, Associate Professor in the cancer prevention program at Fred Hutchinson Cancer Research Center:
“New study on JAMA Oncology highlights long-term risks of prostate cancer treatments!
Patients undergoing prostatectomy or radiotherapy face significant risks of urinary, sexual, and radiation-related complications. Notably, radiation therapy triples bladder cancer risk and increases radiation-specific complications dramatically.
Findings underscore the need for careful patient counseling on risks vs. benefits before PCA treatment decisions! Active surveillance needs to be carefully discussed in low-risk settings to spare toxicity!”
Oliver Hahn, Urologist at University Medical Center Göttingen, shared this post, adding:
“… Which underlines again one thing: urological oncology simply does not work without functional urology – and patients need to be made aware that there is more than just remission status to be taken into account. Very important evidence shared by Niklas Klümper.”
Authors: Joseph Unger,Cathee Till,Catherine Tangen, Howard Parnes, Ian Thompson et al.
More posts featuring Niklas Klümper.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023